Log in

NASDAQ:AIMTAimmune Therapeutics Options Chain and Prices

$14.36
+0.45 (+3.24 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.72
Now: $14.36
$14.38
50-Day Range
$13.21
MA: $15.40
$17.62
52-Week Range
$10.09
Now: $14.36
$37.00
Volume1.12 million shs
Average Volume1.42 million shs
Market Capitalization$939.86 million
P/E RatioN/A
Dividend YieldN/A
Beta0.86

Options Chain

Aimmune Therapeutics (NASDAQ:AIMT) Options Chain

 $ 
ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades
8/21/2020$35.00$0.000Call0000
(+0)
0.00
8/21/2020$30.00$0.000Call0005
(+0)
0.00
8/21/2020$25.00$0.025Call00033
(+0)
1.79302
(+0.171263)
0.0199780
8/21/2020$22.50$0.025Call00069
(+0)
1.52101
(+0.151716)
0.0228830
8/21/2020$20.00$0.025Call000942
(+0)
1.20475
(+0.133257)
0.0277760
8/21/2020$17.50$0.050Call10001001037
(+5)
0.941919
(+0.23645)
0.0623291
8/21/2020$15.00$0.225Call271671143
(+43)
0.700758
(+0.14922)
0.2676518
8/21/2020$12.50$1.600Call000212
(-5)
0.7303080.8634020
8/21/2020$10.00$4.050Call00015
(-1)
1.429980.9546660
8/21/2020$7.50$0.000Call0000
(+0)
0.00
8/21/2020$5.00$0.000Call0000
(+0)
0.00
8/21/2020$2.50$0.000Call0000
(+0)
0.00
8/21/2020$35.00$0.000Put0000
(+0)
0.00
8/21/2020$30.00$0.000Put0000
(+0)
0.00
8/21/2020$25.00$0.000Put0000
(+0)
0.00
8/21/2020$22.50$8.550Put0000
(+0)
1.64548-0.967880
8/21/2020$20.00$0.000Put0001
(+0)
0.00
8/21/2020$17.50$3.550Put000367
(+0)
0.898746
(+0.054081)
-0.9479420
8/21/2020$15.00$1.250Put761623
(+0)
0.720502
(-0.2227)
-0.7267842
8/21/2020$12.50$0.000Put000299
(-45)
0.00
8/21/2020$10.00$0.025Put00026
(+0)
1.22483
(+0.002701)
-0.0238950
8/21/2020$7.50$0.000Put0000
(+0)
0.00
8/21/2020$5.00$0.025Put0000
(+0)
3.31622
(+0.137555)
-0.0089860
8/21/2020$2.50$0.025Put0000
(+0)
5.45733
(+0.257091)
-0.0051140
End-of-day options data provided by Trade Alert and Intrinio.
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.